Patrick O'Neill
Member at Executive Forum
Patrick O'neill
Member at Executive Forum
Greater Boston
Overview
Work Experience
Partner
2022 - Current
MedTech Advantage Fund I (MTAF) focuses on venture investing in a broad selection of early and growth stage medtech companies. The Fund invests in selected graduates of MedTech Innovator (MTI), the world’s largest accelerator for medical devices, digital health, biotech tools, and diagnostic companies. The Fund leverages its unique access to MTI’s deal flow ecosystem of 500+ medtech experts, including large strategic medtech manufacturers.
Member
2022
Executive Forum is a highly engaged community of executives from leading corporations who share a passion for "what's next" to drive the business growth of tomorrow. Since its formation in 1995, the Executive Forum has grown to over 400 members who are the top-most leaders at market moving companies, run portfolios for the most innovative PE firms and serve as directors on boards — public, private and non-profit. Admission to the Executive Forum is based upon a rigorous nomination and review process. By design, approximately half the EF members are President/CEOs, and the others are at the COO, CFO, CMO, CIO and VP levels.
Where collaborative, engaged top talent finds and delivers growth.
Board Member
2020 - 2022
Lumeda is a biotechnology company that enables practical intraoperative photodynamic therapy for treating lung cancer.
Raised $7,350,187.00 from Cycle Venture Partners and Connecticut Innovations.
Managing Director, Venture Capital Investments
2008 - 2022
I led investments in the clean tech, life sciences, industrial tech and enterprise software sectors. My responsibilities include managing due diligence teams, negotiating terms, syndicating investors and serving on the target companies' Boards of Directors. I currently serve on the Boards of several portfolio companies and advise five early stage technology companies.
Board Observer
2020 - 2021
Board Observer
2019 - 2021
Budderfly is an energy management company with devices that measure and report on all elements of energy use.
Raised $282,000,000.00 from Vantage Infrastructure, Nuveen, a TIAA company and Connecticut Green Bank.
Board Member
2019 - 2021
Board Member
2018 - 2021
CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
Raised $8,028,008.00 from MedTech Innovator.
Member Board Of Directors
2017 - 2021
Landsdowne Labs is the newest spin out from the Langer Labs at MIT and the Karp Labs at Harvard. Through the use of advanced materials science, we are solving problems that others are not. We are focused on developing advanced materials for injury prevention, to bring solutions to a set of patients that are often overlooked: children.
Member, Board of Directors
2017 - 2021
Shoreline Biome’s mission is to develop leading-edge microbiome technologies and products and bring this innovative discovery technology to new and experienced microbiome investigators.